• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ANP 0.00% 20.0¢

ANTISENSE THERAPEUTICS LIMITED

Antisense Therapeutics Limited (ANP) is an Australia-based pharmaceutical drug discovery... Antisense Therapeutics Limited (ANP) is an Australia-based pharmaceutical drug discovery and development company. The Company is engaged in the research and development of antisense pharmaceuticals. The Company's product candidate, ATL1103, is an antisense drug designed to block growth hormone receptor (GHr) expression thereby reducing levels of the hormone insulin-like growth factor-I (IGF-I) in the blood. ATL1103 is in clinical development for acromegaly, diabetic retinopathy and diabetic nephropathy. The Company's product candidate, ATL1102, is an antisense inhibitor targeting very late antigen 4 (VLA-4), an immune cell molecule. The Company completed a Phase IIa efficacy and safety trial of ATL1102 in multiple sclerosis (MS) patients. The Company's product candidate, ATL1101, is an antisense inhibitor of insulin like growth factor 1 receptor (IGF-Ir). It is developing ATL1101 for the treatment of prostate cancer. It is also developing ATL1102 as an inhaled treatment for asthma.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ANP 28/03/19 25 15K
28/03/19 Last post  Grae1 Comments Created with Sketch.  25  Views Created with Sketch.  15K 
ANP
Chart
5 6 7
26/03/19 381 88K
26/03/19 Last post  jpkat Comments Created with Sketch.  381  Views Created with Sketch.  88K 
ANP 18/03/19 0 837
18/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  837 
ANP 18/03/19 0 539
18/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  539 
ANP 15/03/19 0 364
15/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  364 
ANP 15/03/19 43 8.1K
15/03/19 Last post  clearview9 Comments Created with Sketch.  43  Views Created with Sketch.  8.1K 
ANP 14/03/19 20 3.4K
14/03/19 Last post  discursive Comments Created with Sketch.  20  Views Created with Sketch.  3.4K 
ANP
News: ANP Antisense Therapeutics Announces Placement Of 48.5 Mln Shares At $0.033 Per Share
13/03/19 0 170
13/03/19 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  170 

See All Discussions arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.